BQST
Bioquest CorpCompany Information
- Company Name
- Bioquest Corp
- CIK
- CIK0001568628
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BQST: OTC
- Fiscal Year End
- April 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BQST
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2022-09-12
- Price on filing date
- —
- 1-month reaction
- -88.21%
- 3-month reaction
- -86.11%
Balance Sheet
Values in millions ($)| Line item | 2022-07-31 | 2022-04-30 | 2022-01-31 | 2021-10-31 | 2021-07-31 | 2021-04-30 | 2021-01-31 | 2020-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
Liabilities Current | ||||||||||||||
| Liabilities Current | 1 | 0 | 0 | 0 | 2 | 2 | 1 | 1 | ||||||
| Employee Related Liabilities Current | - | - | - | - | 2 | 1 | 1 | - | ||||||
| Due To Officers Or Stockholders Current | 0 | 0 | - | - | 0 | 0 | - | - | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Notes Payable Current | - | - | - | 0 | - | - | 0 | 0 | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | - | 0 | 0 | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 1 | 0 | 0 | 0 | 2 | 2 | 0 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||
| Long Term Notes Payable | - | - | - | - | - | - | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | -8 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||
| Stockholders Equity | -1 | -0 | -0 | -0 | -2 | -2 | -1 | -1 | ||||||
| Additional Paid In Capital Common Stock | 10 | 10 | 10 | 10 | 8 | 8 | 8 | 8 | ||||||
| Retained Earnings Accumulated Deficit | -11 | -11 | -10 | -10 | -10 | -10 | -0 | - | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Debt Instrument Unamortized Discount Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 11 | 11 | 11 | 11 | 9 | 9 | 8 | 8 | ||||||
| Shares Outstanding | 11 | 11 | 11 | 11 | 9 | 9 | 8 | 8 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBioquest Corp (BQST) — SEC Financial Statements & Analysis
Bioquest Corp (BQST) is a pharmaceutical preparations company, incorporated in NV. Bioquest Corp trades on OTC as: BQST. Bioquest Corp (BQST)'s most recent SEC filing is a Form 10-Q for the period ended 2022-07-31, filed with the SEC on 2022-09-12. Based on that filing, Bioquest Corp carries a market cap of $10.66M, a P/E ratio of -21.00x, a P/B ratio of -19.86x, a P/S ratio of 7578.76x, an enterprise value of $10.82M, and an EV/EBITDA multiple of -26.83x. On profitability, it posts an operating margin of -269231.42%, a net margin of -279873.44%, a Return on Equity (ROE) of 37.89%, and a Return on Assets (ROA) of -3483.85%. Per share, it reports EPS of $-0.04, diluted EPS of $-0.08, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -81.62% year-over-year, and EPS growth of -85.79% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-536.42K, a debt-to-equity ratio of -1.03x, a debt ratio of 36.87, an interest coverage ratio of -9.88x, free cash flow of $-72.78K (TTM), and net debt of $168.34K. Figures sourced from SEC EDGAR.
- Market Cap
- $10.66M
- P/E TTM
- -21.00x
- EPS TTM
- $-0.04
- P/B TTM
- -19.86x
- ROE TTM
- 37.89%
- ROA TTM
- -3483.85%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-72.78K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2022-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bioquest Corp in?
Bioquest Corp (BQST) operates in the Pharmaceutical Preparations industry.
What exchange does BQST trade on?
Bioquest Corp (BQST) trades on the OTC.
Where is Bioquest Corp incorporated?
Bioquest Corp is incorporated in NV.
When was Bioquest Corp (BQST)'s most recent SEC filing?
Bioquest Corp (BQST)'s most recent SEC filing is a Form 10-Q for the period ended 2022-07-31, filed with the SEC on 2022-09-12.
What is BQST's market cap?
Bioquest Corp (BQST) has a market capitalization of $10.66M as of 2022-07-31.
What is BQST's EPS (earnings per share)?
Bioquest Corp (BQST)'s trailing twelve month EPS is $-0.04 as of 2022-07-31.
What is BQST's ROE (return on equity)?
Bioquest Corp (BQST)'s trailing twelve month Return on Equity (ROE) is 37.89% as of 2022-07-31.
What is BQST's ROA (return on assets)?
Bioquest Corp (BQST)'s trailing twelve month Return on Assets (ROA) is -3483.85% as of 2022-07-31.
What is BQST's EV/EBITDA?
Bioquest Corp (BQST)'s trailing twelve month EV/EBITDA is -26.83x as of 2022-07-31.